✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹2,439 Cr.
P/E
0.00
About
Camlin Fine Sciences Limited is a leading integrated manufacturer of traditional antioxidants and other chemical solutions. They specialize in shelf life solutions, aroma ingredients, health & wellnes… Read more
Camlin Fine Sciences Limited is a leading integrated manufacturer of traditional antioxidants … Read more
Low
78
52W Range
High
142
  • Camlin Fine Sciences
  • Privi Speciality Che
  • Clean Science
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Performance Chemicals

Product Wise Break-Up - Shelf-Life

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Speciality Chemicals (MTPA)
    Peer Comparison
    Suppliers
    • Hindusthan National Glass & Industries Ltd.
    Customers
    • Adani Wilmar Ltd.
    • Cargill
    • Clariant
    • Dow Chemical Company
    • Evonik Industries
    FAQs on Camlin Fine Sciences Ltd. Business

    Camlin Fine Sciences is a reputable manufacturer specializing in traditional antioxidants, aroma ingredients, and performance chemicals, prioritizing quality and customer service to establish a strong presence in the industry.

    Camlin Fine Sciences major competitors are Privi Speciality Che, Clean Science, Vishnu Chemicals, Tatva Chintan Pharma, Tanfac Industries, Ultramar & Pigments, Paushak.
    Market Cap of Camlin Fine Sciences is ₹2,550 Crs.
    While the median market cap of its peers are ₹2,733 Crs.

    Camlin Fine Sciences seems to be less financially stable compared to its competitors.
    Altman Z score of Camlin Fine Sciences is 2.97 and is ranked 8 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material